+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Blue Biotechnology MARKET, BY Product
6.1. Overview
6.2. Enzymes
6.3. Pharma Products
6.4. Bulk Chemicals
6.5. Biopolymers
6.6. Others
7. GLOBAL Blue Biotechnology MARKET, BY Application
7.1. Overview
7.2. Bioengineering
7.3. Genomics
7.4. Vaccine Development
7.5. Drug Discovery
7.6. Others
8. GLOBAL Blue Biotechnology MARKET, BY End-use
8.1. Overview
8.2. Hospitals
8.3. Pharmaceutical Companies
8.4. Biotechnology Companies
8.5. Research Institutes
8.6. Laboratories
8.7. Others
9. GLOBAL Blue Biotechnology MARKET, by Region
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. Competitive Landscape
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Blue Biotechnology Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Blue Biotechnology Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Application Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. Company ProfileS
11.1. Aker BioMarine
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Marinova
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. New England Biolabs
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. PML Applications Ltd.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Sea Run Holdings
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. PICES
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Donald Danforth Plant Science Center
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Shell Marine Products
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. GeoMarine Biotechnologies
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. GlycoMar
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Cellgen Biologicals Pvt Ltd.
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.12. Nurture Aqua Technology Pvt. Ltd.
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.13. Samudra Biopharma Pvt. Ltd
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Products Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.14. Sanosil Biotech
11.14.1. Company Overview
11.14.2. Financial Overview
11.14.3. Products Offered
11.14.4. Key Developments
11.14.5. SWOT Analysis
11.14.6. Key Strategies
12. Appendix
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 Global Blue Biotechnology Market, Synopsis, 2018-2032
TABLE 2 Global Blue Biotechnology Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 6 North America Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 7 North America Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 North America Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 9 North America Blue Biotechnology MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 10 U.S. Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 11 U.S. Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 U.S. Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 13 Canada Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 14 Canada Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 Canada Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 16 Europe Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 17 Europe Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 Europe Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 19 Europe Blue Biotechnology MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 20 Germany Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 21 Germany Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 Germany Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 23 France Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 24 France Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 France Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 26 Italy Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 27 Italy Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 28 Italy Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 29 Spain Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 30 Spain Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 Spain Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 32 U.K Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 33 U.K Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 34 U.K Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 35 Rest of Europe Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 36 Rest of Europe Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 37 Rest of Europe Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 38 Asia Pacific Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 39 Asia Pacific Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 40 Asia Pacific Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 41 Asia Pacific Blue Biotechnology MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 42 Japan Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 43 Japan Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 44 Japan Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 45 China Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 46 China Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 China Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 48 India Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 49 India Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 50 India Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 51 Australia Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 52 Australia Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 53 Australia Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 54 south korea Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 55 south korea Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 56 south korea Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 57 Rest of asia-pacific Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 58 Rest of asia-pacific Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 59 Rest of asia-pacific Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 60 Rest of WOrld Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 61 Rest of WOrld Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 62 Rest of WOrld Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 63 Rest of WOrld Blue Biotechnology MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 64 Middle east Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 65 Middle east Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 66 Middle east Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 67 Africa Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 68 Africa Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 69 Africa Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 70 Latin america Blue Biotechnology MARKET, BY Product, 2018-2032 (USD BILLION)
TABLE 71 Latin america Blue Biotechnology MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 72 Latin america Blue Biotechnology MARKET, BY END-USE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Blue Biotechnology Market
FIGURE 3 Market Dynamics for the Global Blue Biotechnology Market
FIGURE 4 Global Blue Biotechnology Market, Share (%), BY Product, 2022
FIGURE 5 Global Blue Biotechnology Market, Share (%), BY APPLICATION, 2022
FIGURE 6 Global Blue Biotechnology Market, Share (%), BY END-USE, 2022
FIGURE 7 Global Blue Biotechnology Market, Share (%), by Region, 2022
FIGURE 8 north AMERICA: Blue Biotechnology MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Europe: Blue Biotechnology MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Asia-Pacific: Blue Biotechnology MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Rest of the world: Blue Biotechnology MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Global Blue Biotechnology Market: Company Share Analysis, 2022 (%)
FIGURE 13 Aker BioMarine: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 Aker BioMarine: SWOT ANALYSIS
FIGURE 15 Marinova: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 Marinova: SWOT ANALYSIS
FIGURE 17 New England Biolabs: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 New England Biolabs: SWOT ANALYSIS
FIGURE 19 PML Applications Ltd.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 PML Applications Ltd.: SWOT ANALYSIS
FIGURE 21 Sea Run Holdings.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 Sea Run Holdings.: SWOT ANALYSIS
FIGURE 23 PICES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 PICES: SWOT ANALYSIS
FIGURE 25 Donald Danforth Plant Science Center: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 Donald Danforth Plant Science Center: SWOT ANALYSIS
FIGURE 27 Shell Marine Products: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 Shell Marine Products: SWOT ANALYSIS
FIGURE 29 GeoMarine Biotechnologies: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 GeoMarine Biotechnologies: SWOT ANALYSIS
FIGURE 31 GlycoMar: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 GlycoMar: SWOT ANALYSIS
FIGURE 33 Cellgen Biologicals Pvt Ltd.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 Cellgen Biologicals Pvt Ltd.: SWOT ANALYSIS
FIGURE 35 Nurture Aqua Technology Pvt. Ltd.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 Nurture Aqua Technology Pvt. Ltd.: SWOT ANALYSIS
FIGURE 37 Samudra Biopharma Pvt. Ltd: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 Samudra Biopharma Pvt. Ltd: SWOT ANALYSIS
FIGURE 39 Sanosil Biotech: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 Sanosil Biotech: SWOT ANALYSIS
Report Code :
RL6540
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst